Update Thyroid-Associated Ophthalmopathy

References

• Jacobson D. H., Gorman C. A. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocrine Reviews 1984; 5: 200–220
   PubMed Web of Science ®Google Scholar
• Salvi M., Zhang Z. G., Haegert D., et al. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J Clin Endocrinol Metab 1990; 70: 89–94
   PubMed Web of Science ®Google Scholar
• Wiersinga W. M., Smit T., Van der Gaag R., Koornneef L. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. J Endocrinol Invest 1988; 11: 615–619
   PubMed Web of Science ®Google Scholar
• Frecker M., Stenzsky V., Balazs C., Kozma L., Kraszits E., Farid N. R. Genetic factors in Graves' ophthalmopathy. Clin Endocrinol 1986; 25: 479–485
   PubMed Web of Science ®Google Scholar
• Kendall-Taylor P., Stephenson A., Stratton A., Papiha S. S., Perros P., Roberts D. F. Differentiation of autoimmune ophthalmopathy from Graves' hyperthyroidism by analysis of genetic markers. Clin Endocrinol 1988; 28: 601–610
   PubMed Web of Science ®Google Scholar
• Weetman A. P., So A. K., Warner C. A., Foroni L., Fells P., Shine B. lmmunogenetics of Graves' ophthalmopathy. Clin Endocrinol 1988; 28: 619–628
   PubMed Web of Science ®Google Scholar
• Frecker M., Mercer G., Skanes V. M., Farid N. R. Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease. Autoimmunity 1988; 1: 307–315
   PubMedGoogle Scholar
• Weetman A. P., Zhang L., Webb S., Shine B. Analysis of HLA-DQB and HLA-DPB alleles in Graves' disease by oligonucleotide probing of enzymically amplified DNA. Clin Endocrinol 1990; 33: 65–71
   PubMed Web of Science ®Google Scholar
• Inoue D., Sato K., Maeda M., et al. Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy. Clin Endocrinol 1991; 34: 57–62
   PubMed Web of Science ®Google Scholar
• Hagg E., Asplund K. Is endocrine ophthalmopathy related to smoking. Brit J Med 1987; 295: 634–635
   PubMed Web of Science ®Google Scholar
• Shine B., Fells P., Edwards O. M., Weetman A. P. Association between Graves' ophthalmopathy and smoking. Lancet 1990; ii: 1261–1263
   Google Scholar
• Tollerud D., Brown L., Blattner W., Mann D., Pankiw-Trost L., Hoover J. R. Evidence for the influence of race on T cell subset alterations associated with cigarette smoking. FASEB Meeting; Atlanta. 1991, (abstr. 7644)
   Google Scholar
• Hancock S. L., Cox R. S., McDougall I. R. Thyroid diseases after treatment of Hodgkin's disease. New Engl J Med 1991; 325: 599–605
   PubMed Web of Science ®Google Scholar
• Bartalena L., Marcocci C., Bogazzi F., Panicucci M., Lepri A., Pinchera A. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. New Engl J Med 1989; 321: 1349–1352
   PubMed Web of Science ®Google Scholar
• McGregor A. M., Petersen M. M., Capiferri R., Evered D. C., Rees Smith B., Hall R. Effects of radioiodine on thyrotrophin binding inhibiting immunoglobulins in Graves' disease. Clin Endocrinol 1979; 11: 437–444
   PubMed Web of Science ®Google Scholar
• Teng W. P., Stark R., Munro A. J., McHardy-Young S., Borysiewicz L. K., Weetman A. P. Peripheral blood T cell activation after radioiodine treatment for Graves' disease. Acta Endocrinol 1990; 122: 233–240
   PubMedGoogle Scholar
• Gwinup G., Elias A. N., Ascher M. S. Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA 1982; 247: 2135–2138
   PubMed Web of Science ®Google Scholar
• Smith T. J., Bahn R. S., Gorman C. A. Hormonal regulation of hyal-uronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts. J Clin Endocrinol Metab 1989; 69: 1019–1023
   PubMed Web of Science ®Google Scholar
• Kahaly G., Schuler M., Sewell A. C., Bernard G., Beyer J., Krause U. Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol 1990; 33: 35–44
   PubMed Web of Science ®Google Scholar
• Campbell R. J. Pathology of Graves' ophthalmopathy. The Eye and Orbit in Thyroid Disease, C. A. Gorman, R. A. Waller, J. A. Dyer. Raven Press, New York 1984; 25–31
   Google Scholar
• Tallstedt L., Norberg R. Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophthal 1988; 29: 175–184
   Google Scholar
• Weetman A. P., Cohen S., Gatter K. C., Fells P., Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989; 75: 222–227
   PubMed Web of Science ®Google Scholar
• Small R. G. Enlargement of levator palpebrae superioris muscle fibers in Graves' ophthalmopathy. Ophthalmology 1989; 96: 424–430
   PubMed Web of Science ®Google Scholar
• Atkinson S., Holcombe M., Kendall-Taylor P. Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy. Lancet 1984; ii: 374–376
   Google Scholar
• Kadlubowski M., Irvine W. J., Rowland A. C. The lack of specificity of ophthalmic immunoglobulins in Graves' disease. J Clin Endocrinol Metab 1986; 63: 990–995
   PubMed Web of Science ®Google Scholar
• Ahmann A., Baker J. R., Weetman A. P., Wartofsky L., Nutman T. B., Burman K. D. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy; identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 1987; 64: 454–460
   PubMed Web of Science ®Google Scholar
• Miller A., Sikorska H., Salvi M., Wall J. R. Evaluation of an enzyme-linked immunosorbent assay for the measurement of autoantibodies against eye muscle membrane antigens in Graves' ophthalmopathy. Acta Endocrinol 1986; 113: 514–522
   PubMedGoogle Scholar
• Weetman A. P., Fells P., Shine B. T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy. Brit J Ophthal 1989; 73: 323–327
   PubMed Web of Science ®Google Scholar
• Schifferdecker E., Ketzler-Sasse U., Boehm B. O., Ronsheimer H. B., Scherbaum W. A., Schoffling K. Re-evaluation of eye muscle autoantibody determination in Graves' ophthalmopathy; failure to detect a specific antigen by use of enzyme-linked immunosorbent assay, indirect immunofluorescence, and immunoblotting techniques. Acta Endocrinol 1989; 121: 643–650
   PubMedGoogle Scholar
• Kadlubowski M., Irvine W. J., Rowland A. C. Anti-muscle antibodies in Graves' ophthalmopathy. J Clin Lab Immunol 1987; 24: 105–111
   PubMedGoogle Scholar
• Salvi M., Hiromatsu Y., Bernard N., How J., Wall J. R. Human orbital tissue and thyroid membrane express a 64 kDa protein which is recognised by autoantibodies in serum of patients with thyroid-associated ophthalmopathy. FEBS Lett 1988; 232: 135–139
   PubMed Web of Science ®Google Scholar
• Bahn R. S., Gorman C. A., Johnson C. M., Smith T. J. Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein. J Clin Endocrinol Metab 1989; 69: 622–628
   PubMed Web of Science ®Google Scholar
• Weightman D., Kendall-Taylor P. Cross-reaction of eye muscle antibodies with thyroid tissue in thyroid-associated ophthalmopathy. /. Endocrinol 1989; 122: 201–206
   Web of Science ®Google Scholar
• Kendler D. L., Huber G. K., Rootman J., Davies T. F. A 64 kd antigen associated with Graves' ophthalmopathy is amphiphilic and present in retro-orbital muscle, skeletal muscle and thyroid tissue. The Endocrine Society Annual Meeting, Washington, D.C., 1991, (abstr. 1137)
   Google Scholar
• Salvi M., Bernard N., Miller A., Zhang Z., Gardini E., Wall J. R. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid 1991; 1: 207–213
   PubMedGoogle Scholar
• Dong Q., Ludgate M., Vassart G. Cloning and sequencing of a novel 64 Kd autoantigen recognised by patients with autoimmune thryoid disease. J Clin Endocrinol Metab 1991; 72: 1375–1381
   PubMed Web of Science ®Google Scholar
• Wall J. R., Salvi M., Bernard N. F., Boucher A., Haegert D. Thyroid-associated ophthalmopathy-a model for the association of organ-specific autoimmune disorders. Immunol Today 1991; 12: 150–153
   PubMedGoogle Scholar
• Perros P., Kendall-Taylor P. Eye muscle growth-stimulating antibodies in thyroid-associated ophthalmopathy. Quart Med 1991; 80: 782, (abstract)
   Google Scholar
• Van der Gaag R., Broersma L., Mourits M., et al. Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity. Clin Exp Immunol 1989; 75: 275–279
   PubMed Web of Science ®Google Scholar
• Prummel M. F., Van der Gaag R., Mourits M., Koornneef L. Serum soluble interleukin-2 receptor (sIL2R) in Graves' ophthalmopathy. Ann Endocrinol 1991; 52: 64, (abstr.)
   Google Scholar
• Dillon J., Zhang Z. -G., Hiromatsu N., Bernard M., Salvi M., Wall J. R. Failure to detect complement-mediated antibody-dependent cytotoxicity against human orbital tissue cells in the serum of patients with thyroid-associated ophthalmopathy. Autoimmunity 1989; 5: 125–132
   PubMed Web of Science ®Google Scholar
• Rotella C. M., Zonefrati R., Toccafondi R., Valente W. A., Kohn L. D. Ability of monoclonal antibodies to the thyrotrophin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab 1986; 62: 357
   PubMed Web of Science ®Google Scholar
• Westermark K., Lilja K., Karlsson F. A. Effects of sera and immunoglobulin preparations from patients with endocrine ophthalmopathy on the production of hyaluronate and the incorporation of tritiated thymidine in fibroblasts. Acta Endocrinol 1989; 121(Suppl 2)85–89
   Google Scholar
• Tao T. -W., Leu S. -L., Kriss J. P. Biological activity of autoantibodies associated with Graves' dermopathy. J Clin Endocrinol Metab 1989; 69: 90–99
   PubMed Web of Science ®Google Scholar
• Sheilds C. L., Nelson L. B., Carpenter G. C., Sheilds J. A. Neonatal Graves' disease. Brit J Ophthal 1988; 72: 424–427
   PubMed Web of Science ®Google Scholar
• Smith T. J., Bahn R. S., Gorman C. A., Cheavens M. Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. J Clin Endocrinol Metab 1991; 72: 1169–1171
   PubMed Web of Science ®Google Scholar
• Heufelder A. E., Smith T. J., Gorman C. A., Bahn R. S. Increased induction of HLA-DR by interferon-)' in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretib-ial dermopathy. J Clin Endocrinol Metab 1991; 73: 307–313
   PubMed Web of Science ®Google Scholar
• Chang T. C., Kao S. C. S., Huang K. M. Octreotide and Graves' ophthalmopathy and pretibial myxoedema. Brit Med J 1992; 304: 158
   PubMed Web of Science ®Google Scholar
• Hansson H. -A. Aspects on growth factors in exophthalmos. Acta Endocrinol 1989; 121(Suppl 2)107–111
   PubMedGoogle Scholar